Status:
COMPLETED
Assessment of Left-sided Cardiac Sparing Through the Use of 3-dimensional Surface Matching-based Deep Inspiration Breath Hold and Active Breathing Control
Lead Sponsor:
Sunnybrook Health Sciences Centre
Conditions:
Left-Sided Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The standard treatment for breast cancer is surgery followed by adjuvant breast radiation therapy in most cases. For left sided breast cancers, the heart dose delivered by the radiation treatment is o...
Eligibility Criteria
Inclusion
- Women with diagnosis of left-sided breast malignancy
- Women who require left chest wall or breast irradiation status post mastectomy or lumpectomy
- Treatment with modified wide tangents to include IMCs
- Treatment with four-field technique
- Age \>18 years
- Performance status ECOG \<3
- Patient must be able to maintain a 30 second breath hold
- Conventional chest wall or breast radiation delivery dose of 50Gy/25 or hypofractionated chest wall/breast radiation delivery dose of 42.56Gy/16 with or without a boost
Exclusion
- Right sided breast cancer patients
- Treatment with partial breast irradiation
- Previous left breast/chest wall irradiation
- Locally advanced breast cancer
- Pregnant patients
- Unable to follow commands
Key Trial Info
Start Date :
May 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03459898
Start Date
May 19 2018
End Date
January 30 2022
Last Update
May 5 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada, M4N 3M5